Search - tctmd.com

Displaying 441 - 460 of 1039

Sort: Relevancy | Date

News Conference News CRT 2016

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

Shelley Wood

February 21, 2016

Presentation JIM 2016

The Drug-Filled Stent and the Start of RevElution

Presenter: Gregg W. Stone

February 10, 2016

News Conference News ISET 2016

Tumors, Bad Backs, and Cataracts: Interventional Physicians Face a Lifetime of Risk

Michael O'Riordan

February 09, 2016

Presentation JIM 2016

ABSORB BVS:What Have we Learned?

Presenter: Gregg W. Stone

February 09, 2016

Presentation

Timing of Clopidogrel Loading in US Practice

Presenter: Gregg W. Stone

February 08, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

February 08, 2016

News Opinion Editor's Corner

数据的礼物：医学期刊支持将数据公开披露作为发表的前提

Shelley Wood

January 24, 2016

News Opinion Editor's Corner

The Gift of Data: Medical Journals Back Public Data Disclosure as Prerequisite for Publishing

Shelley Wood

January 24, 2016

News Opinion Editor's Corner

El Regalo de los Datos: Las Revistas Médicas Exigen que se Hagan Públicos los Datos como un Requisito Indispensable en Materia de Publicación

Shelley Wood

January 24, 2016

Presentation

AHA Late Breaking Trials: What's more appropriate? IVUS or appropriate use criteria?

Presenter: Gregg W. Stone

January 19, 2016

News Features

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Michael O'Riordan

January 06, 2016

News Industry News

Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension

January 05, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

Yael L. Maxwell

January 05, 2016

News Daily News

It’s Official: Europe Bans Direct Industry Sponsorship of Physicians for CME

Todd Neale

December 02, 2015

Presentation

TCT 2015 Late Breaking Trials: LEADERS FREE and RESPECT LATE

Presenter: Gregg W. Stone

November 23, 2015

News Daily News

ILUMIEN II Raises Questions as to What OCT Offers Over IVUS

Caitlin E. Cox

November 16, 2015

News Conference News AHA 2015

RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life

L.A. McKeown

November 09, 2015

News Features

精益求精：创新支架技术值得继续探索

Todd Neale

November 08, 2015

News Features

La Innovación en Tecnologías Stent es Posible y algo que Merece la Pena Perseguir

Todd Neale

November 08, 2015

Advertisement

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

The Drug-Filled Stent and the Start of RevElution

Tumors, Bad Backs, and Cataracts: Interventional Physicians Face a Lifetime of Risk

ABSORB BVS:What Have we Learned?

Timing of Clopidogrel Loading in US Practice

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

数据的礼物：医学期刊支持将数据公开披露作为发表的前提

The Gift of Data: Medical Journals Back Public Data Disclosure as Prerequisite for Publishing

El Regalo de los Datos: Las Revistas Médicas Exigen que se Hagan Públicos los Datos como un Requisito Indispensable en Materia de Publicación

AHA Late Breaking Trials: What's more appropriate? IVUS or appropriate use criteria?

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

La Duración de los Síntomas Podría ser Más Importante que el Tiempo Puerta-Balón en el Manejo de Los Cuadros de STEMI, según un Subestudio del HORIZONS-AMI

It’s Official: Europe Bans Direct Industry Sponsorship of Physicians for CME

TCT 2015 Late Breaking Trials: LEADERS FREE and RESPECT LATE

ILUMIEN II Raises Questions as to What OCT Offers Over IVUS

RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life

精益求精：创新支架技术值得继续探索

La Innovación en Tecnologías Stent es Posible y algo que Merece la Pena Perseguir

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content